Adeline Unterreiner
Basel, BS 4002, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement.
Journal: Journal of medicinal chemistry
Published: October 15, 2025
HDAC6/aggresome processing pathway importance for inflammasome formation is context dependent.
Journal: bioRxiv : the preprint server for biology
Published: August 30, 2023
HDAC6/aggresome processing pathway importance for inflammasome formation is context-dependent.
Journal: The Journal of biological chemistry
Published: August 21, 2023
Evaluation of protein kinase D auto-phosphorylation as biomarker for NLRP3 inflammasome activation.
Journal: PloS one
Published: March 01, 2021
Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1.
Journal: Biochemical and biophysical research communications
Published: January 15, 2021
CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo.
Journal: Oncogenesis
Published: December 11, 2020
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity.
Journal: Journal of visualized experiments : JoVE
Published: January 22, 2019
MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
Journal: Biochemical and biophysical research communications
Published: September 20, 2018
Selective MALT1 paracaspase inhibition does not block TNF-α production downstream of TLR4 in myeloid cells.
Journal: Immunology letters
Published: October 20, 2017
A CARD10-Dependent Tonic Signalosome Activates MALT1 Paracaspase and Regulates IL-17/TNF-α-Driven Keratinocyte Inflammation.
Journal: The Journal of investigative dermatology
Published: October 15, 2017
The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition.
Journal: Immunology and cell biology
Published: May 16, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026